Skip to main content
Retour
Watch Compare

HARVARD BIOSCIENCE INC

Qualité des données : 100%
HBIO
Nasdaq Manufacturing Measuring & Analyzing Instruments
5,38 €
▼ 0,17 € (-3,06%)
Cap. Boursière: 24,06 M
Prix
5,38 €
Cap. Boursière
24,06 M
Fourchette du Jour
5,37 € — 5,55 €
Fourchette 52 Semaines
2,80 € — 9,50 €
Volume
21 191
Ouverture 5,55 €
Moyenne 50J / 200J
5,39 €
0,16% below
Moyenne 50J / 200J
5,40 €
0,30% below

Quick Summary

Points Clés

Revenue declined -7,63% annually over 5 years
Debt/Equity of 2,41 — high leverage
Generating 5,47 M in free cash flow
Capital efficient — spends only 1,45% of revenue on capex

Croissance

Revenue Growth (5Y)
-7,63%
En dessous de la moyenne du secteur (1,82%)
Revenue (1Y)-8,06%
Earnings (1Y)N/A
FCF Growth (3Y)-33,14%

Qualité

Return on Equity
-380,52%
En dessous de la moyenne du secteur (-53,41%)
ROIC-158,30%
Net Margin-65,51%
Op. Margin-56,13%

Sécurité

Debt / Equity
2,41
Au-dessus de la moyenne du secteur (0,31)
Current Ratio0,81
Interest Coverage-13,49

Valorisation

PE (TTM)
-0,42
Au-dessus de la moyenne du secteur (-1,48)
P/B Ratio1,71
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E -0,4 -1,5
P/B 1,7 1,6
ROE % -380,5 -53,4
Net Margin % -65,5 -41,5
Rev Growth 5Y % -7,6 1,8
D/E 2,4 0,3

ETFs Holding This Stock

GSSC logo GSSC Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF
0,00% weight
BDSIX BDSIX
0,00% weight
BDSAX BDSAX
0,00% weight
BDSCX BDSCX
0,00% weight
BDSKX BDSKX
0,00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) -8,06% Revenue Growth (3Y) -12,19%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -7,63% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 86,55 M Net Income (TTM) -56,70 M
ROE -380,52% ROA -71,73%
Gross Margin 57,67% Operating Margin -56,13%
Net Margin -65,51% Free Cash Flow (TTM) 5,47 M
ROIC -158,30% FCF Growth (3Y) -33,14%
Safety
Debt / Equity 2,41 Current Ratio 0,81
Interest Coverage -13,49 Asset Turnover 1,10
Working Capital -10,59 M Tangible Book Value -3,84 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,42 Forward P/E N/A
P/B Ratio 1,71 P/S Ratio 0,28
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 22,74%
Market Cap 24,06 M Enterprise Value 51,21 M
Per Share
EPS (Diluted TTM) -1,28 Revenue / Share 19,35
FCF / Share 1,22 OCF / Share 1,50
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 1,45% FCF Conversion -9,65%
SBC-Adj. FCF 3,02 M Growth Momentum -0,43

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 86,55 M 94,14 M 112,25 M 113,34 M 118,90 M
Net Income -56,70 M -12,41 M -3,42 M -9,52 M -288 000,0
EPS (Diluted) -1,28 -0,28 -0,08 — —
Gross Profit 49,91 M 54,77 M 66,07 M 60,82 M 67,65 M
Operating Income -48,58 M -6,21 M 1,89 M -6,93 M 2,07 M
EBITDA — — — — —
R&D Expenses 8,83 M 10,41 M 11,76 M 12,33 M 10,80 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 3,60 M — — — —
Income Tax -686 000,0 740 000,0 859 000,0 337 000,0 148 000,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 80,07 M 126,64 M 137,37 M 145,36 M 162,34 M
Total Liabilities 66,34 M 63,30 M 64,29 M 73,14 M 78,94 M
Shareholders' Equity 13,73 M 63,34 M 73,07 M 72,22 M 83,40 M
Total Debt 35,87 M 36,96 M 36,56 M 46,82 M 48,33 M
Cash & Equivalents 8,61 M 4,11 M 4,28 M 4,51 M 7,82 M
Current Assets 48,23 M 45,12 M 49,04 M 51,12 M 61,58 M
Current Liabilities 21,96 M 54,96 M 26,54 M 23,25 M 25,32 M